Search published articles


Showing 2 results for Coronavirus

Arezoo Monfared, Mohammad Taghi Moghadamnia, Samad Karkhah, Saman Maroufizadeh, Mohammad Asadian Rad, Jalal Kheirkhah, Fatemeh Jafaraghayee,
Volume 9, Issue 4 (12-2021)
Abstract

Background and Objective: In the current COVID-19 pandemic, disease diagnosis is essential for optimal management and timely isolation of infected cases in order to prevent further spread. The aim of this study is to assess of predictors of mortality among COVID-19 patients.
Material and Methods: In a retrospective study, 522 COVID-19 patients were enrolled in Razi hospital, Guilan Province, Iran. This hospital was the main center for the treatment of COVID-19 patients in Guilan province. Data gathering was performed by census sampling from March to August 2020. Simple and Multiple logistic regression analysis was applied to assess the relationships of clinical and demographic characteristics with in-hospital mortality.
Results: Multiple logistic regression showed that older age (aOR=1.04, 95%CI: 1.02 to 1.06, P<0.001), decreased O2 saturation (aOR=0.89, 95%CI: 0.86 to 0.92, P<0.001), having a dysrhythmia (aOR=2.97, 95%CI: 1.46 to 6.05, P=0.003), symptoms associated with heart failure (aOR=0.43, 95%CI: 0.18 to 0.99, P=0.048), and mixed drug antiviruses (aOR=2.44, 95%CI: 1.22 to 4.90, P=0.012) were mortality predictor variables among COVID-19 patients.
Conclusion: Therefore, special attention should be paid to the factors influencing the mortality of COVID-19 patients. It is recommended that older patients, dysrhythmia, and symptoms associated with heart failure be treated with extreme caution.

Narges Marefati, Hassan Ghoshooni, Mostafa Mahabadi,
Volume 11, Issue 3 (12-2023)
Abstract

It seems necessary to understand the association of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), with its entering bronchoalveolar and brain cells, which have a high concentration of angiotensin-converting enzyme 2 (ACE2). Although the virus infects healthy people, the rate of infection and mortality is higher and significant in vulnerable people, such as drug users and addicts who have acute and chronic respiratory disease. It also places a heavy economic burden on families and societies around the world. Thus, researchers are aiming to provide prevention and treatment strategies to people at risk. The purpose of the present study was to collect studies on the rate of infection with coronavirus in people who abuse drugs. Besides, the role of the ACE2 receptor as a key factor in coronavirus infectivity in these people was investigated. Our narrative review on the relationship between COVID-19 and opioid abuse and smoking, with consideration of ACE2's role, contains original and human studies. According to the results of the current study, those who smoke or are dependent on opioids are much more likely to experience COVID-19-related respiratory side effects or even pass away.
 


Page 1 from 1     

© 2025 CC BY-NC 4.0 | Jorjani Biomedicine Journal

Designed & Developed by : Yektaweb